Biostatistics Practice Questions

Q: In an outbreak of cholera in a village with a population of 2,000, 20 cases have occurred and 5 individuals died. What is the case fatality rate?

25%. ### Explanation **1. Understanding the Correct Answer (D: 25%)** The **Case Fatality Rate (CFR)** is a measure of the severity of a disease. It represents the proportion of cases of a specified disease that result in death within a specific time frame. The formula for CFR is: $$\text{CFR} = \frac{\text{Total number of deaths due to a disease}}{\text{Total number of cases of that disease}} \times 100$$ In this scenario: * Total deaths = 5 * Total cases = 20 * Calculation: $(5 / 20) \times 100 = 25\%$ **2. Analysis of Incorrect Options** * **Option A (1%):** This is the **Crude Death Rate** (Total deaths / Total population $\times$ 1000), which would be $(5 / 2000) \times 1000 = 2.5$ per 1000. 1% is a mathematical miscalculation. * **Option B (0.25%):** This represents the **Mortality Rate** expressed as a percentage of the total population $(5 / 2000) \times 100$. It incorrectly uses the population as the denominator instead of the number of cases. * **Option C (5%):** This is the **Attack Rate** or Incidence $(20 / 2000) \times 100 = 1\%$. 5% is a distractor based on the number of deaths. **3. High-Yield Clinical Pearls for NEET-PG** * **Denominator Difference:** Remember that **Mortality Rate** uses the *total population at risk*, while **Case Fatality Rate** uses the *total diagnosed cases*. * **Significance:** CFR reflects the **virulence** of the pathogen and the effectiveness of treatment. * **Cholera Specifics:** With prompt rehydration therapy, the CFR of Cholera can be reduced to **less than 1%**. A CFR of 25% indicates a severe outbreak or poor access to medical care. * **Complementary Concept:** CFR is the complement of the **Survival Rate** (Survival Rate = 100 – CFR). In this case, the survival rate is 75%.

Q: Which of the following statements is NOT true regarding non-randomized trials?

The degree of comparability is high.. In epidemiology, the hallmark of a **Randomized Controlled Trial (RCT)** is randomization, which ensures that both known and unknown confounding factors are distributed equally between the study and control groups, leading to a high degree of comparability. **Why Option B is the correct answer (The statement is NOT true):** In **non-randomized trials** (quasi-experimental designs), the investigator lacks the mechanism of randomization. Consequently, the study and control groups are often inherently different regarding baseline characteristics, age, sex, or disease severity. Therefore, the **degree of comparability is low**, making the results more susceptible to selection bias and confounding compared to RCTs. **Analysis of other options:** * **Option A:** The *approach* to comparability is high because the researcher actively attempts to make groups comparable through methods like matching or statistical adjustments, even if a high *degree* of actual comparability is not always achieved. * **Option C:** This is a feature of specific non-randomized designs. In **"Before and After" trials** (without control), the experiment serves as its own control. In **Natural Experiments**, researchers utilize naturally occurring groups (e.g., populations separated by a geographic boundary or a disaster) as controls. * **Option D:** Because non-randomized trials are prone to bias, a single study is rarely definitive. Multiple trials across different settings are usually required to establish a consistent association or effect. **NEET-PG High-Yield Pearls:** * **Randomization** is the "Heart of a Clinical Trial"; it eliminates **Selection Bias**. * **Blinding** eliminates **Measurement/Observer Bias**. * **Quasi-experimental designs** are used when randomization is unethical or impractical. * **Historical controls** are a type of non-randomized trial where current patients are compared with records of past patients.

Q: Which of the following are components of validity?

Sensitivity and specificity. ### Explanation **Validity** (also known as accuracy) refers to the ability of a screening or diagnostic test to distinguish between those who have the disease and those who do not. It measures how close the test result is to the "true" value (the Gold Standard). #### 1. Why Option A is Correct Validity is composed of two fundamental components: * **Sensitivity:** The ability of a test to correctly identify those who **have** the disease (True Positive Rate). * **Specificity:** The ability of a test to correctly identify those who **do not have** the disease (True Negative Rate). Together, these parameters define the inherent accuracy of a diagnostic tool, independent of the disease prevalence in the population. #### 2. Why Other Options are Incorrect * **Option B (Precision):** Precision (or reliability/reproducibility) refers to the consistency of a test when repeated under the same conditions. A test can be precise (giving the same result every time) without being valid (giving the wrong result every time). * **Option C (Acceptability):** This is a practical attribute of a screening test, referring to how well the target population tolerates the procedure (e.g., non-invasiveness, cost). While important for a screening program, it is not a statistical component of validity. #### 3. High-Yield Clinical Pearls for NEET-PG * **Validity vs. Reliability:** Think of a target—Validity is hitting the **bullseye**; Reliability is hitting the **same spot** repeatedly. * **Yield:** This is the amount of previously undiagnosed disease detected in the community; it depends on the test's sensitivity and the prevalence of the disease. * **Predictive Values:** Unlike sensitivity/specificity, Positive and Negative Predictive Values are **highly dependent on the prevalence** of the disease in the population being tested. * **Ideal Test:** A perfect test has 100% sensitivity and 100% specificity.

Q: Receiver operator characteristic (ROC) curve is usually drawn between which of the following parameters?

Sensitivity and (1 - specificity). ### Explanation The **Receiver Operating Characteristic (ROC) curve** is a fundamental graphical tool used in biostatistics to evaluate the diagnostic accuracy of a test with continuous outcomes (e.g., blood glucose levels) and to determine the optimal **cut-off point**. #### Why Option A is Correct An ROC curve is plotted on a graph where: * **Y-axis (Vertical):** Represents the **Sensitivity** (True Positive Rate). * **X-axis (Horizontal):** Represents **1 - Specificity** (False Positive Rate). The curve illustrates the trade-off between sensitivity and specificity at various threshold settings. As you lower the threshold to increase sensitivity (catching more cases), you inevitably increase the false positive rate (decreasing specificity). #### Why Other Options are Incorrect * **Option B & D:** These involve (1 - sensitivity), which represents the **False Negative Rate**. While mathematically related, they are not standard parameters for plotting an ROC curve. * **Option C:** While the ROC curve helps determine the relationship between sensitivity and specificity, it does not plot them directly against each other. Plotting sensitivity against specificity would result in a curve moving in the opposite direction, which is not the standard convention. #### High-Yield Clinical Pearls for NEET-PG * **Area Under the Curve (AUC):** This measures the overall accuracy of the test. An AUC of **1.0** represents a perfect test, while an AUC of **0.5** (the diagonal line) indicates a test no better than random chance. * **The "Ideal" Point:** The top-left corner of the graph (0,1) represents 100% sensitivity and 100% specificity. The point on the curve closest to this corner is often chosen as the **optimal cut-off**. * **Utility:** ROC curves are excellent for comparing two different diagnostic tests; the one with the larger AUC is the superior test.

Q: An ECG was performed on 700 subjects with complaints of acute chest pain. Of these, 520 patients had myocardial infarction. Calculate the specificity of the ECG. The results are presented in the table below: MYOCARDIAL INFARCTION ECG PRESENT | ECG ABSENT | TOTAL POSITIVE | 416 | 9 | 425 NEGATIVE | 104 | 171 | 275 TOTAL | 520 | 180 | 700

95%. ### Explanation **1. Understanding the Correct Answer (D: 95%)** In biostatistics, **Specificity** is the ability of a test to correctly identify those **without** the disease (True Negatives). It is calculated using the formula: $$\text{Specificity} = \frac{\text{True Negatives (TN)}}{\text{True Negatives (TN)} + \text{False Positives (FP)}} \times 100$$ From the provided 2x2 contingency table: * **Disease Absent (No MI):** 180 subjects (Total of the "ECG Absent" column). * **True Negatives (TN):** 171 (Negative ECG in patients without MI). * **False Positives (FP):** 9 (Positive ECG in patients without MI). Calculation: $$\text{Specificity} = \frac{171}{171 + 9} \times 100 = \frac{171}{180} \times 100 = 95\%$$ **2. Why Other Options are Incorrect** * **Option C (80%):** This represents the **Sensitivity** of the test. Sensitivity measures the ability to identify those *with* the disease. Calculation: $\frac{\text{True Positives}}{\text{Total Diseased}} = \frac{416}{520} \times 100 = 80\%$. * **Option B (55%):** This is a distractor value roughly corresponding to the ratio of True Negatives to the total number of negative test results (Negative Predictive Value is actually 62%). * **Option A (20%):** This represents the **False Negative Rate** ($1 - \text{Sensitivity}$), where 104/520 = 20%. **3. Clinical Pearls for NEET-PG** * **SNOUT:** **S**ensitivity rules **OUT** (High sensitivity means a negative result reliably excludes the disease). * **SPIN:** **S**pecificity rules **IN** (High specificity means a positive result reliably confirms the disease). * **Prevalence Independence:** Sensitivity and Specificity are inherent properties of a test and do not change with disease prevalence, unlike Predictive Values (PPV/NPV). * **Screening vs. Diagnosis:** Screening tests require high sensitivity; confirmatory (diagnostic) tests require high specificity.

Q: What is the purpose of double blinding in clinical trials?

To avoid both observer and subject bias. **Explanation** In clinical trials, **blinding** (or masking) is a fundamental epidemiological tool used to eliminate **bias**—the systematic error that can influence the results of a study. **Why Option D is Correct:** Double blinding is the gold standard in clinical trials where **neither the investigator (observer) nor the participant (subject)** knows which group (study or control) the subject has been assigned to. * **Avoiding Subject Bias:** If a patient knows they are receiving a new "miracle drug," they may report subjective improvement due to the placebo effect or psychological expectations. * **Avoiding Observer Bias:** If the researcher knows who is receiving the intervention, they may subconsciously measure outcomes more favorably or provide extra care to the study group, skewing the data. **Analysis of Incorrect Options:** * **Option A:** Comparability between groups is achieved through **Randomization**, not blinding. Randomization ensures that both known and unknown confounding factors are distributed equally. * **Option B & C:** These are components of double blinding, but individually they describe **Single Blinding** (where only the subject is unaware). Option D is the most comprehensive answer for "double" blinding. **High-Yield Clinical Pearls for NEET-PG:** * **Single Blind:** Only the subject is unaware. * **Double Blind:** Subject and Investigator are unaware. (Most common in RCTs). * **Triple Blind:** Subject, Investigator, and the **Data Analyst** (Statistician) are unaware. This is the most secure method to prevent bias. * **The "Placebo"** is the tool used to maintain blinding. * **Randomization** is the "Heart of a Control Trial"; it eliminates **Selection Bias**.

Q: The formula (A/A+C) x 100, based on the provided table which shows test results, represents which of the following?

Sensitivity. ***Sensitivity*** - The formula **A/(A+C) × 100** represents the proportion of **true positives** (A) out of all individuals who actually have the disease (A+C). - **Sensitivity** measures the test's ability to correctly identify **disease-positive cases**, answering "What percentage of diseased individuals test positive?" *Specificity* - Specificity is calculated as **D/(B+D) × 100**, where D represents **true negatives** and B represents **false positives**. - It measures the test's ability to correctly identify **disease-negative cases**, not what the given formula represents. *Positive Predictive Value (PPV)* - PPV is calculated as **A/(A+B) × 100**, representing **true positives** out of all **positive test results**. - It answers "What percentage of positive test results are truly positive?" which differs from the given formula. *Negative Predictive Value (NPV)* - NPV is calculated as **D/(C+D) × 100**, representing **true negatives** out of all **negative test results**. - It measures the probability that a **negative test result** is truly negative, unrelated to the given formula.

Q: If the lifetime probability of developing lung cancer is 25%, what are the odds of developing lung cancer in a lifetime?

1:3. ### Explanation **Understanding the Concept: Probability vs. Odds** In biostatistics, **Probability (P)** is the likelihood of an event occurring out of the total number of possible outcomes. **Odds**, however, is the ratio of the probability of the event occurring to the probability of the event *not* occurring. The formula to convert Probability to Odds is: $$\text{Odds} = \frac{P}{1 - P}$$ **Calculation for this Question:** 1. **Given Probability (P):** 25% or 0.25. 2. **Probability of NOT developing cancer (1 - P):** $1 - 0.25 = 0.75$ (or 75%). 3. **Odds Calculation:** $\frac{0.25}{0.75} = \frac{1}{3}$. 4. **Expressed as a ratio:** 1:3. --- ### Analysis of Options * **Option B (1:3) [Correct]:** As calculated, for every 1 person who develops lung cancer, 3 people do not. * **Option A (3:1):** This represents the "Odds Against" the event or the inverse ratio. It would be correct if the question asked for the odds of *not* developing lung cancer. * **Option D (1:4):** This is a common distractor where students confuse odds with probability. 1/4 is the probability (25%), not the odds. --- ### NEET-PG High-Yield Clinical Pearls * **Odds Ratio (OR):** This is the measure of association used in **Case-Control studies**. It compares the odds of exposure in cases to the odds of exposure in controls. * **Relative Risk (RR):** This is used in **Cohort studies**. It is a ratio of *probabilities* (Incidence among exposed / Incidence among non-exposed). * **Key Rule:** When a disease is rare (low prevalence), the Odds Ratio becomes a good approximation of the Relative Risk. * **Memory Aid:** Probability is "Part over Whole," while Odds is "Part over Remaining Part."

Q: What happens to the minimum sample size when the range of allowable error is doubled?

It is reduced to 1/4. ### Explanation **1. Why the Correct Answer is Right** In biostatistics, the formula for calculating the minimum sample size ($n$) for a qualitative variable is: $$n = \frac{Z^2 \cdot p \cdot q}{L^2}$$ *(Where $Z$ is the confidence level, $p$ is prevalence, $q$ is $1-p$, and $L$ is the allowable error/precision).* The relationship between sample size ($n$) and allowable error ($L$) is an **inverse square relationship** ($n \propto 1/L^2$). * If the allowable error is **doubled** ($2L$), the new sample size becomes $1/(2)^2$, which is **1/4th** of the original size. * Conversely, if you want to increase precision by halving the error, you would need to quadruple (4x) the sample size. **2. Why the Incorrect Options are Wrong** * **Option A (1/2):** This assumes a linear relationship ($n \propto 1/L$). However, because error is squared in the denominator, the reduction is much steeper than half. * **Option C (1/16):** This would occur if the allowable error were quadrupled ($4L$), as $1/4^2 = 1/16$. * **Option D:** This is factually incorrect. Allowable error is one of the most critical determinants of sample size; the smaller the error you are willing to accept, the larger the sample you must study. **3. High-Yield Clinical Pearls for NEET-PG** * **Precision vs. Sample Size:** Precision is the "allowable error." High precision = Small allowable error = Large sample size. * **Standard Error (SE):** $SE = \sigma / \sqrt{n}$. As sample size increases, the standard error decreases, leading to narrower Confidence Intervals. * **Power of Study:** Usually set at 80%. Increasing the power also increases the required sample size. * **Alpha Error (Type I):** Usually set at 5% ($Z = 1.96$). Decreasing the alpha error (e.g., to 1%) increases the required sample size.

Q: Which of the following properties is NOT possessed by an interval variable?

True zero. In biostatistics, variables are classified into four levels of measurement (NOIR: Nominal, Ordinal, Interval, and Ratio). Understanding the hierarchy of these scales is crucial for selecting appropriate statistical tests. **Explanation of the Correct Answer:** The correct answer is **D (True zero)**. An **Interval scale** possesses identity, magnitude, and equal intervals between values, but it lacks an **absolute or "true" zero**. In an interval scale, zero is arbitrary and does not represent the total absence of the quantity being measured. * *Example:* Temperature in Celsius. 0°C does not mean "no temperature"; it is simply a point on the scale. Because there is no true zero, you cannot say 40°C is "twice as hot" as 20°C. A true zero is only found in **Ratio scales** (e.g., Height, Weight, BP). **Analysis of Incorrect Options:** * **A. Identity:** This is the most basic property (found in Nominal scales). it means different numbers represent different categories (e.g., Male=1, Female=2). * **B. Magnitude:** This means the numbers have a relative order or rank (found in Ordinal scales). One value can be identified as greater than or less than another. * **C. Equidistance:** This is the hallmark of the Interval scale. The physical distance between 10 and 20 is exactly the same as between 30 and 40. **High-Yield Clinical Pearls for NEET-PG:** * **NOIR Mnemonic:** **N**ominal (Name only), **O**rdinal (Order/Rank), **I**nterval (Equal distance), **R**atio (True zero). * **IQ Scores and Temperature (C/F):** Classic examples of Interval scales. * **Kelvin Scale:** Unlike Celsius, Kelvin is a **Ratio scale** because 0 K represents absolute zero (no molecular motion). * **Statistical Test Rule:** For Interval and Ratio data, use **Parametric tests** (e.g., t-test, ANOVA) if normally distributed. For Nominal and Ordinal data, use **Non-parametric tests** (e.g., Chi-square, Mann-Whitney U).

Question 1

In an outbreak of cholera in a village with a population of 2,000, 20 cases have occurred and 5 individuals died. What is the case fatality rate?

Accepted Answer

25%

Answer

1%

Answer

0.25%

Answer

5%

Question 2

Which of the following statements is NOT true regarding non-randomized trials?

Accepted Answer

The degree of comparability is high.

Answer

The approach to comparability is high.

Answer

The experiment can serve as its own control or can utilize a natural control.

Answer

Several trials may be needed before evaluation is considered conclusive.

Question 3

Which of the following are components of validity?

Accepted Answer

Sensitivity and specificity

Answer

Precision

Answer

Acceptability

Answer

None of the above

Question 4

Receiver operator characteristic (ROC) curve is usually drawn between which of the following parameters?

Accepted Answer

Sensitivity and (1 - specificity)

Answer

(1 - sensitivity) and specificity

Answer

Sensitivity and specificity

Answer

(1 - sensitivity) and (1 - specificity)

Question 5

An ECG was performed on 700 subjects with complaints of acute chest pain. Of these, 520 patients had myocardial infarction. Calculate the specificity of the ECG. The results are presented in the table below:

MYOCARDIAL INFARCTION
ECG PRESENT | ECG ABSENT | TOTAL
POSITIVE    | 416        | 9           | 425
NEGATIVE    | 104        | 171         | 275
TOTAL       | 520        | 180         | 700

Accepted Answer

95%

Answer

20%

Answer

55%

Answer

80%

Question 6

What is the purpose of double blinding in clinical trials?

Accepted Answer

To avoid both observer and subject bias

Answer

To achieve comparability between study and control groups

Answer

To avoid observer bias

Answer

To avoid subject bias

Question 7

The formula (A/A+C) x 100, based on the provided table which shows test results, represents which of the following?

Accepted Answer

Sensitivity

Answer

Specificity

Answer

Positive Predictive Value (PPV)

Answer

Negative Predictive Value (NPV)

Question 8

If the lifetime probability of developing lung cancer is 25%, what are the odds of developing lung cancer in a lifetime?

Accepted Answer

1:3

Answer

3:1

Answer

1:4

Question 9

What happens to the minimum sample size when the range of allowable error is doubled?

Accepted Answer

It is reduced to 1/4

Answer

It is reduced to 1/2

Answer

It is reduced to 1/16

Answer

The sample size does not depend on the acceptable error

Question 10

Which of the following properties is NOT possessed by an interval variable?

Accepted Answer

True zero

Answer

Identity

Answer

Magnitude

Answer

Equidistance

Biostatistics — MCQs

Biostatistics — MCQs

On this page

Practice by Chapter

Want unlimited practice?